Found: 9
Select item for more details and to access through your institution.
PREDICTORS OF RE-EXCISION FINDINGS AND IPSILATERAL BREAST TUMOR RECURRENCE AFTER BREAST CONSERVATION THERAPY.
- Published in:
- Current Medical Literature: Breast Cancer, 2004, v. 16, n. 4, p. 73
- By:
- Publication type:
- Article
A phase II study of the efficacy and safety of AMG 102 in patients with metastatic renal cell carcinoma.
- Published in:
- BJU International, 2011, v. 108, n. 5, p. 679, doi. 10.1111/j.1464-410X.2010.09947.x
- By:
- Publication type:
- Article
Women's use of resources in decision-making for early-stage breast cancer: Results of a community-based survey.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 1997, v. 4, n. 7, p. 564, doi. 10.1007/BF02305537
- By:
- Publication type:
- Article
Population pharmacokinetics and exposure-response of trastuzumab emtansine in advanced breast cancer previously treated with ≥2 HER2-targeted regimens.
- Published in:
- British Journal of Clinical Pharmacology, 2017, v. 83, n. 12, p. 2767, doi. 10.1111/bcp.13381
- By:
- Publication type:
- Article
Exposure-response analyses of trastuzumab emtansine in patients with HER2-positive advanced breast cancer previously treated with trastuzumab and a taxane.
- Published in:
- 2017
- By:
- Publication type:
- journal article
The results of radical prostatectomy at a community hospital during the prostate specific antigen era.
- Published in:
- 1996
- By:
- Publication type:
- journal article
The importance of the lumpectomy surgical margin status in long-term results of breast conservation.
- Published in:
- 1995
- By:
- Publication type:
- journal article
A phase II study evaluating the efficacy and safety of AMG 102 (rilotumumab) in patients with recurrent glioblastoma.
- Published in:
- Neuro-Oncology, 2011, v. 13, n. 4, p. 437, doi. 10.1093/neuonc/noq198
- By:
- Publication type:
- Article
Relationship between tumor biomarkers and efficacy in TH3RESA, a phase III study of trastuzumab emtansine (T-DM1) vs. treatment of physician's choice in previously treated HER2-positive advanced breast cancer.
- Published in:
- International Journal of Cancer, 2016, v. 139, n. 10, p. 2336, doi. 10.1002/ijc.30276
- By:
- Publication type:
- Article